CN Stock MarketDetailed Quotes

300485 Beijing Science Sun Pharmaceutical

Watchlist

7.14
-0.12-1.65%

Market Closed Dec 30 15:00 CST

3.44BMarket Cap-17.94P/E (TTM)

Beijing Science Sun Pharmaceutical Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Assets

Current assets

Money funds

-46.27%108.35M

-67.26%71.2M

-38.48%126.24M

-46.88%120.16M

68.65%201.67M

91.18%217.46M

-10.64%205.2M

40.03%226.21M

-69.72%119.58M

-72.03%113.75M

Transactional financial assets

59.65%1.42B

33.61%1.14B

19.56%1.1B

17.65%1.05B

-23.15%890.08M

-24.97%854.63M

-12.13%921.14M

-21.08%895.39M

35.13%1.16B

47.15%1.14B

Notes receivable and accounts receivable

-17.46%56.19M

-16.70%56.59M

-33.41%52.91M

-38.16%52.42M

-30.52%68.08M

-21.98%67.93M

-11.30%79.46M

-11.88%84.76M

-4.44%97.98M

-27.30%87.07M

-Notes receivable

-25.30%4.62M

-41.01%3.94M

-57.00%4.4M

-37.76%5.46M

-27.89%6.19M

27.78%6.68M

115.14%10.23M

75.48%8.78M

1,048.58%8.58M

-65.84%5.23M

-Accounts receivable

-16.67%51.57M

-14.05%52.65M

-29.93%48.52M

-38.21%46.95M

-30.77%61.89M

-25.15%61.25M

-18.39%69.23M

-16.68%75.98M

-12.17%89.4M

-21.65%81.84M

Other receivables (including interest and dividends)

-72.99%1.14M

-68.20%1.32M

4.34%4.52M

-1.60%4.01M

180.57%4.22M

1.70%4.17M

-11.12%4.33M

315.67%4.08M

-2.69%1.5M

295.59%4.1M

-Other receivable

----

-68.20%1.32M

----

1.70%4.17M

----

315.67%4.08M

----

295.59%4.1M

Advance payment

10.03%5.07M

-23.51%3.44M

-97.53%115.25K

41.08%5.35M

297.62%4.61M

211.54%4.5M

74.70%4.66M

275.34%3.79M

-70.01%1.16M

51.84%1.44M

Inventories

-16.86%90.18M

-2.78%96.45M

11.29%108.46M

20.17%107.06M

27.03%108.47M

-0.96%99.22M

-11.25%97.46M

-27.60%89.09M

-38.36%85.39M

-34.62%100.17M

Other current assets

-7.83%7.48M

13.88%9.7M

-52.21%8.06M

-37.81%10.65M

1,018.07%8.12M

194.91%8.52M

72.15%16.86M

33.50%17.12M

-82.22%726.15K

-68.16%2.89M

Total current assets

31.45%1.69B

9.88%1.38B

5.45%1.4B

2.47%1.35B

-12.24%1.29B

-13.26%1.26B

-11.08%1.33B

-13.71%1.32B

-2.54%1.46B

-1.12%1.45B

Non Current assets

Other non-current financial assets

-65.62%256.03M

-30.63%545.82M

-14.06%482.98M

10.91%631.81M

29.98%744.74M

39.07%786.82M

23.05%561.97M

46.00%569.67M

138.28%572.96M

147.40%565.76M

Long-term equity investment

-13.64%719.91M

-18.50%727.61M

-14.28%702.52M

-3.22%802.91M

21.07%833.61M

29.01%892.82M

28.15%819.54M

33.38%829.62M

49.48%688.52M

47.87%692.08M

Fixed assets

----

-7.22%499.01M

----

-7.86%537.86M

----

5.99%559.46M

----

7.10%583.72M

Constru in process

----

183.87%1.37M

----

--482.24K

----

-99.54%327.52K

----

Productive biological assets

20.10%6.86M

2.45%5.95M

--6.15M

--5.53M

--5.71M

--5.81M

----

Intangible assets

-5.76%47.96M

-7.43%47.84M

-7.24%48.91M

-7.12%49.95M

-7.95%50.89M

-8.26%51.68M

-8.13%52.72M

-7.98%53.78M

8.51%55.28M

3.60%56.34M

Development expenditure

29.29%261.17M

27.47%247.95M

12.33%209.4M

13.53%208.97M

14.16%202M

17.64%194.51M

15.69%186.42M

16.12%184.07M

16.31%176.95M

8.71%165.34M

Goodwill

0.00%21.87M

Long deferred expense

----

--0

----

Deferred tax assets

-55.69%2.34M

-56.24%2.35M

-44.81%2.52M

-54.52%2.42M

108.12%5.27M

112.89%5.38M

76.75%4.57M

111.61%5.33M

-8.73%2.53M

5.81%2.53M

Usufruct assets

-2.35%11.85M

-2.33%11.93M

-2.85%11.96M

-2.83%12.04M

--12.13M

--12.22M

--12.31M

--12.4M

----

Other non current assets

-2.40%11.21M

-1.37%11.4M

4.18%11.45M

-2.75%11.79M

-20.00%11.49M

4.56%11.56M

-80.50%10.99M

-36.23%12.12M

3.86%14.36M

-51.27%11.06M

Total non current assets

-24.42%1.83B

-15.78%2.12B

-9.50%2.01B

0.91%2.27B

14.85%2.42B

20.12%2.52B

11.99%2.22B

20.15%2.25B

36.15%2.11B

34.41%2.1B

Total assets

-5.03%3.52B

-7.25%3.5B

-3.90%3.41B

1.49%3.62B

3.74%3.7B

6.49%3.78B

2.07%3.55B

4.92%3.57B

17.09%3.57B

17.21%3.55B

Liabilities

Current liabilities

Notes payable and accounts payable

10.30%11.49M

-2.73%11.11M

-23.32%16.37M

-29.97%15.13M

-59.61%10.42M

-56.78%11.42M

26.01%21.35M

-21.21%21.61M

14.92%25.79M

-1.03%26.42M

-Accounts payable

10.30%11.49M

-2.73%11.11M

-23.32%16.37M

-29.97%15.13M

-59.61%10.42M

-56.78%11.42M

26.01%21.35M

-21.21%21.61M

14.92%25.79M

-1.03%26.42M

Contract liabilities

-0.86%6.42M

0.94%5.64M

-40.14%5.12M

-30.65%6.08M

-23.17%6.48M

-45.43%5.59M

-26.21%8.56M

-28.67%8.77M

10.64%8.43M

5.57%10.24M

Advance receipts

----

0.00%352.29K

----

28.00%352.29K

--0

----

Salaries payable

-14.18%4.54M

-17.25%4.55M

-14.60%4.92M

-8.65%4.76M

16.31%5.29M

23.42%5.5M

19.19%5.76M

-14.08%5.21M

-2.90%4.55M

-23.50%4.46M

Taxs payable

15.30%2.13M

-28.82%2.19M

-22.21%2.64M

-58.94%1.34M

-78.74%1.84M

-32.53%3.07M

-50.01%3.4M

-54.35%3.27M

-14.87%8.68M

-33.97%4.55M

Other payable (including interest and dividends)

326.43%57.69M

122.97%50.12M

143.52%37.42M

-33.52%22.99M

-5.05%13.53M

89.21%22.48M

180.48%15.37M

2.00%34.59M

-68.41%14.25M

-82.95%11.88M

-Other payable

----

122.97%50.12M

----

89.21%22.48M

----

2.00%34.59M

----

-82.95%11.88M

Non current liabilities due within one year

----

--0

----

Other current liabilities

-0.86%835.17K

0.94%733.21K

-40.14%665.87K

-30.65%790.65K

-23.17%842.46K

-45.43%726.36K

-26.21%1.11M

-14.26%1.14M

10.64%1.1M

5.57%1.33M

Total current liabilities

116.41%83.11M

52.38%74.33M

20.88%67.14M

-31.34%51.45M

-38.84%38.4M

-17.15%48.78M

17.79%55.54M

-15.29%74.94M

-31.02%62.8M

-50.96%58.88M

Current liabilities

Deferred tax liabilities

-20.44%80.25M

-25.05%80.37M

-16.46%67.81M

25.56%103.16M

96.50%100.87M

108.21%107.22M

99.68%81.16M

173.12%82.16M

613.50%51.33M

800.70%51.5M

Total non current liabilities

-20.44%80.25M

-25.05%80.37M

-16.46%67.81M

25.56%103.16M

96.50%100.87M

108.21%107.22M

99.68%81.16M

173.12%82.16M

613.50%51.33M

800.70%51.5M

Total liabilities

17.30%163.36M

-0.83%154.7M

-1.29%134.94M

-1.58%154.61M

22.03%139.27M

41.34%156M

55.70%136.7M

32.52%157.1M

16.18%114.13M

-12.25%110.38M

Shareholders equity

Paid-in capital

0.00%481.67M

Capital reserve funds

0.00%845.93M

0.28%845.93M

0.63%843.56M

Surplus reserve funds

0.00%244.68M

9.74%244.68M

27.53%222.96M

Retained profit

-10.35%1.75B

-13.15%1.75B

-7.21%1.67B

3.42%1.86B

4.57%1.96B

8.59%2.01B

-0.20%1.8B

6.01%1.8B

31.95%1.87B

35.66%1.85B

Other composite income

-61.89%534.61K

-30.30%1.14M

803.34%978.73K

181.85%917.04K

40.38%1.4M

273.69%1.63M

94.95%-139.16K

112.43%325.37K

148.30%999.33K

57.17%-940.3K

Shareholders equity without minority interests

-5.76%3.33B

-7.39%3.32B

-3.82%3.25B

1.84%3.44B

3.22%3.53B

5.46%3.59B

0.69%3.37B

3.98%3.37B

17.50%3.42B

18.95%3.4B

Minority interests

-20.89%27.57M

-20.86%28.46M

-20.76%29.85M

-17.09%31.58M

-4.52%34.85M

-2.84%35.97M

0.07%37.67M

-0.74%38.09M

-10.43%36.5M

-12.45%37.02M

Total shareholder equity

-5.91%3.35B

-7.52%3.35B

-4.00%3.28B

1.63%3.47B

3.13%3.56B

5.37%3.62B

0.68%3.41B

3.93%3.41B

17.12%3.46B

18.49%3.44B

Total liabilityies and equity

-5.03%3.52B

-7.25%3.5B

-3.90%3.41B

1.49%3.62B

3.74%3.7B

6.49%3.78B

2.07%3.55B

4.92%3.57B

17.09%3.57B

17.21%3.55B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Grant Thornton Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Assets
Current assets
Money funds	-46.27%108.35M	-67.26%71.2M	-38.48%126.24M	-46.88%120.16M	68.65%201.67M	91.18%217.46M	-10.64%205.2M	40.03%226.21M	-69.72%119.58M	-72.03%113.75M
Transactional financial assets	59.65%1.42B	33.61%1.14B	19.56%1.1B	17.65%1.05B	-23.15%890.08M	-24.97%854.63M	-12.13%921.14M	-21.08%895.39M	35.13%1.16B	47.15%1.14B
Notes receivable and accounts receivable	-17.46%56.19M	-16.70%56.59M	-33.41%52.91M	-38.16%52.42M	-30.52%68.08M	-21.98%67.93M	-11.30%79.46M	-11.88%84.76M	-4.44%97.98M	-27.30%87.07M
-Notes receivable	-25.30%4.62M	-41.01%3.94M	-57.00%4.4M	-37.76%5.46M	-27.89%6.19M	27.78%6.68M	115.14%10.23M	75.48%8.78M	1,048.58%8.58M	-65.84%5.23M
-Accounts receivable	-16.67%51.57M	-14.05%52.65M	-29.93%48.52M	-38.21%46.95M	-30.77%61.89M	-25.15%61.25M	-18.39%69.23M	-16.68%75.98M	-12.17%89.4M	-21.65%81.84M
Other receivables (including interest and dividends)	-72.99%1.14M	-68.20%1.32M	4.34%4.52M	-1.60%4.01M	180.57%4.22M	1.70%4.17M	-11.12%4.33M	315.67%4.08M	-2.69%1.5M	295.59%4.1M
-Other receivable	----	-68.20%1.32M	----	----	----	1.70%4.17M	----	315.67%4.08M	----	295.59%4.1M
Advance payment	10.03%5.07M	-23.51%3.44M	-97.53%115.25K	41.08%5.35M	297.62%4.61M	211.54%4.5M	74.70%4.66M	275.34%3.79M	-70.01%1.16M	51.84%1.44M
Inventories	-16.86%90.18M	-2.78%96.45M	11.29%108.46M	20.17%107.06M	27.03%108.47M	-0.96%99.22M	-11.25%97.46M	-27.60%89.09M	-38.36%85.39M	-34.62%100.17M
Other current assets	-7.83%7.48M	13.88%9.7M	-52.21%8.06M	-37.81%10.65M	1,018.07%8.12M	194.91%8.52M	72.15%16.86M	33.50%17.12M	-82.22%726.15K	-68.16%2.89M
Total current assets	31.45%1.69B	9.88%1.38B	5.45%1.4B	2.47%1.35B	-12.24%1.29B	-13.26%1.26B	-11.08%1.33B	-13.71%1.32B	-2.54%1.46B	-1.12%1.45B
Non Current assets
Other non-current financial assets	-65.62%256.03M	-30.63%545.82M	-14.06%482.98M	10.91%631.81M	29.98%744.74M	39.07%786.82M	23.05%561.97M	46.00%569.67M	138.28%572.96M	147.40%565.76M
Long-term equity investment	-13.64%719.91M	-18.50%727.61M	-14.28%702.52M	-3.22%802.91M	21.07%833.61M	29.01%892.82M	28.15%819.54M	33.38%829.62M	49.48%688.52M	47.87%692.08M
Fixed assets	----	-7.22%499.01M	----	----	----	-7.86%537.86M	----	5.99%559.46M	----	7.10%583.72M
Constru in process	----	183.87%1.37M	----	----	----	--482.24K	----	-99.54%327.52K	----	----
Productive biological assets	20.10%6.86M	2.45%5.95M	--6.15M	--5.53M	--5.71M	--5.81M	----	----	----	----
Intangible assets	-5.76%47.96M	-7.43%47.84M	-7.24%48.91M	-7.12%49.95M	-7.95%50.89M	-8.26%51.68M	-8.13%52.72M	-7.98%53.78M	8.51%55.28M	3.60%56.34M
Development expenditure	29.29%261.17M	27.47%247.95M	12.33%209.4M	13.53%208.97M	14.16%202M	17.64%194.51M	15.69%186.42M	16.12%184.07M	16.31%176.95M	8.71%165.34M
Goodwill	0.00%21.87M	0.00%21.87M	0.00%21.87M	0.00%21.87M	0.00%21.87M	0.00%21.87M	0.00%21.87M	0.00%21.87M	0.00%21.87M	0.00%21.87M
Long deferred expense	----	----	----	----	----	----	----	--0	----	----
Deferred tax assets	-55.69%2.34M	-56.24%2.35M	-44.81%2.52M	-54.52%2.42M	108.12%5.27M	112.89%5.38M	76.75%4.57M	111.61%5.33M	-8.73%2.53M	5.81%2.53M
Usufruct assets	-2.35%11.85M	-2.33%11.93M	-2.85%11.96M	-2.83%12.04M	--12.13M	--12.22M	--12.31M	--12.4M	----	----
Other non current assets	-2.40%11.21M	-1.37%11.4M	4.18%11.45M	-2.75%11.79M	-20.00%11.49M	4.56%11.56M	-80.50%10.99M	-36.23%12.12M	3.86%14.36M	-51.27%11.06M
Total non current assets	-24.42%1.83B	-15.78%2.12B	-9.50%2.01B	0.91%2.27B	14.85%2.42B	20.12%2.52B	11.99%2.22B	20.15%2.25B	36.15%2.11B	34.41%2.1B
Total assets	-5.03%3.52B	-7.25%3.5B	-3.90%3.41B	1.49%3.62B	3.74%3.7B	6.49%3.78B	2.07%3.55B	4.92%3.57B	17.09%3.57B	17.21%3.55B
Liabilities
Current liabilities
Notes payable and accounts payable	10.30%11.49M	-2.73%11.11M	-23.32%16.37M	-29.97%15.13M	-59.61%10.42M	-56.78%11.42M	26.01%21.35M	-21.21%21.61M	14.92%25.79M	-1.03%26.42M
-Accounts payable	10.30%11.49M	-2.73%11.11M	-23.32%16.37M	-29.97%15.13M	-59.61%10.42M	-56.78%11.42M	26.01%21.35M	-21.21%21.61M	14.92%25.79M	-1.03%26.42M
Contract liabilities	-0.86%6.42M	0.94%5.64M	-40.14%5.12M	-30.65%6.08M	-23.17%6.48M	-45.43%5.59M	-26.21%8.56M	-28.67%8.77M	10.64%8.43M	5.57%10.24M
Advance receipts	----	----	----	0.00%352.29K	----	----	----	28.00%352.29K	--0	----
Salaries payable	-14.18%4.54M	-17.25%4.55M	-14.60%4.92M	-8.65%4.76M	16.31%5.29M	23.42%5.5M	19.19%5.76M	-14.08%5.21M	-2.90%4.55M	-23.50%4.46M
Taxs payable	15.30%2.13M	-28.82%2.19M	-22.21%2.64M	-58.94%1.34M	-78.74%1.84M	-32.53%3.07M	-50.01%3.4M	-54.35%3.27M	-14.87%8.68M	-33.97%4.55M
Other payable (including interest and dividends)	326.43%57.69M	122.97%50.12M	143.52%37.42M	-33.52%22.99M	-5.05%13.53M	89.21%22.48M	180.48%15.37M	2.00%34.59M	-68.41%14.25M	-82.95%11.88M
-Other payable	----	122.97%50.12M	----	----	----	89.21%22.48M	----	2.00%34.59M	----	-82.95%11.88M
Non current liabilities due within one year	----	----	----	----	----	----	----	--0	----	----
Other current liabilities	-0.86%835.17K	0.94%733.21K	-40.14%665.87K	-30.65%790.65K	-23.17%842.46K	-45.43%726.36K	-26.21%1.11M	-14.26%1.14M	10.64%1.1M	5.57%1.33M
Total current liabilities	116.41%83.11M	52.38%74.33M	20.88%67.14M	-31.34%51.45M	-38.84%38.4M	-17.15%48.78M	17.79%55.54M	-15.29%74.94M	-31.02%62.8M	-50.96%58.88M
Current liabilities
Deferred tax liabilities	-20.44%80.25M	-25.05%80.37M	-16.46%67.81M	25.56%103.16M	96.50%100.87M	108.21%107.22M	99.68%81.16M	173.12%82.16M	613.50%51.33M	800.70%51.5M
Total non current liabilities	-20.44%80.25M	-25.05%80.37M	-16.46%67.81M	25.56%103.16M	96.50%100.87M	108.21%107.22M	99.68%81.16M	173.12%82.16M	613.50%51.33M	800.70%51.5M
Total liabilities	17.30%163.36M	-0.83%154.7M	-1.29%134.94M	-1.58%154.61M	22.03%139.27M	41.34%156M	55.70%136.7M	32.52%157.1M	16.18%114.13M	-12.25%110.38M
Shareholders equity
Paid-in capital	0.00%481.67M	0.00%481.67M	0.00%481.67M	0.00%481.67M	0.00%481.67M	0.00%481.67M	0.00%481.67M	0.00%481.67M	0.00%481.67M	0.00%481.67M
Capital reserve funds	0.00%845.93M	0.00%845.93M	0.00%845.93M	0.00%845.93M	0.28%845.93M	0.28%845.93M	0.28%845.93M	0.28%845.93M	0.63%843.56M	0.63%843.56M
Surplus reserve funds	0.00%244.68M	0.00%244.68M	0.00%244.68M	0.00%244.68M	9.74%244.68M	9.74%244.68M	9.74%244.68M	9.74%244.68M	27.53%222.96M	27.53%222.96M
Retained profit	-10.35%1.75B	-13.15%1.75B	-7.21%1.67B	3.42%1.86B	4.57%1.96B	8.59%2.01B	-0.20%1.8B	6.01%1.8B	31.95%1.87B	35.66%1.85B
Other composite income	-61.89%534.61K	-30.30%1.14M	803.34%978.73K	181.85%917.04K	40.38%1.4M	273.69%1.63M	94.95%-139.16K	112.43%325.37K	148.30%999.33K	57.17%-940.3K
Shareholders equity without minority interests	-5.76%3.33B	-7.39%3.32B	-3.82%3.25B	1.84%3.44B	3.22%3.53B	5.46%3.59B	0.69%3.37B	3.98%3.37B	17.50%3.42B	18.95%3.4B
Minority interests	-20.89%27.57M	-20.86%28.46M	-20.76%29.85M	-17.09%31.58M	-4.52%34.85M	-2.84%35.97M	0.07%37.67M	-0.74%38.09M	-10.43%36.5M	-12.45%37.02M
Total shareholder equity	-5.91%3.35B	-7.52%3.35B	-4.00%3.28B	1.63%3.47B	3.13%3.56B	5.37%3.62B	0.68%3.41B	3.93%3.41B	17.12%3.46B	18.49%3.44B
Total liabilityies and equity	-5.03%3.52B	-7.25%3.5B	-3.90%3.41B	1.49%3.62B	3.74%3.7B	6.49%3.78B	2.07%3.55B	4.92%3.57B	17.09%3.57B	17.21%3.55B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Grant Thornton Certified Public Accountants (Special General Partnership)	--	--	--	Grant Thornton Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Symbol Price % Chg

Flaircomm Microelectronics, Inc.